• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 382554
Device Problems Device Disinfection Or Sterilization Issue (2909); Device Packaging Compromised (2916)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/22/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that before use a bd insyte autoguard bc shielded iv catheter was found with sterile breech as "packet adhesive appears degraded, packets opening spontaneously therefore no longer sterile." there was no report of exposure, injury or medical intervention needed.
 
Manufacturer Narrative
Investigation summary: device/batch history record review findings: review was previously conducted for this lot (pr 194737-201797 cr) which disclosed the following: lot 6349926: was built on afa line 9 from 20dec2016 through 22dec16 and packaged on packaging line 11 from 27dec2016 through 28dec2016 for the quantity of 109,610ea.It was concluded that all required challenges samples and testing was performed per specification in accordance with the set-up and in process sampling plans.It was noted that there were no reject activity findings throughout the build of this lot that would impact upon the quality of the product.All set-up and in-process inspections include but not limited to blister thickness, bad seal/cut/holes, seal transfer width and package leak test.These were performed on various stages throughout the process, all the inspections passed per specifications.The peura (end user risk analysis) was analyzed to determine the risk to customer.The analysis showed that current risk is acceptable.Occurrence and severity rankings have not changed.Observations and testing: received two unused 16ga bd insyte autoguard blood control catheter units within a partially opened package from lot 6349926.All components were present and intact with the blister packs opened at both ends.Visual/microscopic examination: observed that although the unit packages had partially open seal at the top and bottom of the blister pack, the unit packages had an adequate seal with no anomalies at time of manufacturing.Note: the product characteristics require a minimum of 1/8¿ seal transfer.This characteristic was met.In addition the paper top web of the returned unit was analyzed under uv light.The glue used to seal the top and bottom webs is uv fluorescent.The analysis revealed adequate top web adhesive.The key variables that affect seal strength are: seal transfer/width and top web glue.Both of these variables were included in the investigation.Although the packages were partially opened at the top and bottom, the units received and evaluated for this incident were acceptable per the manufacturing specification requirements of the unit packages.There was no physical evidence to confirm or to support manufacturing process related issues for the defect.Capa 48637 was initiated to address the issue of open seal complaints.Tasks associated with the capa plan have been completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key7603010
MDR Text Key111716876
Report Number1710034-2018-00314
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903825548
UDI-Public30382903825548
Combination Product (y/n)N
PMA/PMN Number
K110443
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 06/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/14/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date11/30/2019
Device Catalogue Number382554
Device Lot Number6349926
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/04/2018
Date Manufacturer Received05/25/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-